MarketScreener Strategies Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.010 USD | -5.05% |
|
-17.08% | +9.45% |
| 07-09 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
| 07-08 | Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- CATX Stock
- News Perspective Therapeutics, Inc.
- MarketScreener Strategies
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
